{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:01:07Z","timestamp":1785135667027,"version":"3.55.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023322","name":"University of Szeged Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023322","name":"University of Szeged Albert Szent-Gy\u00f6rgyi Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.pnpbp.2026.111795","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:20:50Z","timestamp":1781626850000},"page":"111795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Long-term cuprizone administration resulted in cognitive decline and kynurenine metabolic disturbance: novel findings"],"prefix":"10.1016","volume":"148","author":[{"given":"Helga","family":"Poly\u00e1k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Galla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di\u00e1na","family":"Martos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia","family":"Rajda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Monostori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Kliv\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2026.111795_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbi.2015.07.016","article-title":"Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms","volume":"51","author":"Aeinehband","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40001-023-01079-6","article-title":"Association between cognitive impairment and motor dysfunction among patients with multiple sclerosis: a cross-sectional study","volume":"28","author":"Alharthi","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0015","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/brain\/awn119","article-title":"Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"131","author":"Anderson","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(88)90813-0","article-title":"The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection","volume":"90","author":"Andin\u00e9","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4137\/IJTR.S13256","article-title":"Sustained elevation of kynurenic acid in the cerebrospinal fluid of patients with herpes simplex virus type 1 encephalitis","volume":"6","author":"Atlas","year":"2013","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mehy.2018.06.021","article-title":"Hypothesis kynurenic and quinolinic acids: the main players of the kynurenine pathway and opponents in inflammatory disease","volume":"118","author":"Badawy","year":"2018","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110770","article-title":"Kynurenine pathway and human systems","volume":"129","author":"Badawy","year":"2020","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2017.12.001","article-title":"Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training","volume":"314","author":"Bansi","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0045","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0024-3205(02)02365-2","article-title":"Kynurenines and the respiratory parameters on rat heart mitochondria","volume":"72","author":"Baran","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/FBP.0000000000000477","article-title":"The \u2018yin\u2019 and the \u2018Yang\u2019 of the kynurenine pathway: excitotoxicity and neuroprotection imbalance in stress-induced disorders","volume":"30","author":"Barone","year":"2019","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0055","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","article-title":"Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues","volume":"19","author":"Benedict","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061564","article-title":"Kynurenines in the pathogenesis of multiple sclerosis: therapeutic perspectives","volume":"9","author":"Biernacki","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(88)90814-X","article-title":"Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors","volume":"151","author":"Birch","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0070","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.4049\/jimmunol.164.6.3283","article-title":"The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and \u22121 beta in macrophages","volume":"164","author":"Bosco","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fneur.2019.00261","article-title":"Cognitive impairment in multiple sclerosis with regards to disease duration and clinical phenotypes","volume":"10","author":"Brochet","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12020183","article-title":"Cognitive impairment in secondary progressive multiple sclerosis: effect of disease duration, age, and progressive phenotype","volume":"12","author":"Brochet","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.133","article-title":"An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation","volume":"6","author":"Brundin","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2022.1025","article-title":"Association of Brain Atrophy with Disease Progression Independent of relapse activity in patients with relapsing multiple sclerosis","author":"Cagol","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0095","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1021\/acschemneuro.9b00265","article-title":"Neuronal proteins as targets of 3-hydroxykynurenine: implications in neurodegenerative diseases","volume":"10","author":"Capucciati","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0100","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.1038\/s41598-021-89335-9","article-title":"Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder","volume":"11","author":"Cathomas","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0105","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0306-4522(00)00504-2","article-title":"Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis","volume":"102","author":"Chiarugi","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jorganchem.2015.01.005","article-title":"Iron chelation and redox chemistry of anthranilic acid and 3-hydroxyanthranilic acid: a comparison of two structurally related kynurenine pathway metabolites to obtain improved insights into their potential role in neurological disease development","volume":"782","author":"Chobot","year":"2015","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.09.034","article-title":"The Janus faces of 3-hydroxykynurenine: dual redox modulatory activity and lack of neurotoxicity in the rat striatum","volume":"1589","author":"Col\u00edn-Gonz\u00e1lez","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4137\/IJTR.S4282","article-title":"On the biological importance of the 3-hydroxyanthranilic acid: anthranilic acid ratio","volume":"3","author":"Darlington","year":"2010","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577163","article-title":"Enhanced cognitive performance in experimental autoimmune encephalomyelitis mice treated with dimethyl fumarate after the appearance of disease symptoms","volume":"340","author":"das Neves","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0130","doi-asserted-by":"crossref","first-page":"9968","DOI":"10.3390\/ijms23179968","article-title":"The role of tryptophan metabolites in neuropsychiatric disorders","volume":"23","author":"Davidson","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaneurol.2020.4920","article-title":"Identifying the distinct cognitive phenotypes in multiple sclerosis","volume":"78","author":"De Meo","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0140","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/jnnp.2004.045872","article-title":"Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis","volume":"76","author":"Deloire","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0145","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1017\/S1355617704107030","article-title":"Cognitive impairment in relapsing and primary progressive multiple sclerosis: mostly a matter of speed","volume":"10","author":"Denney","year":"2004","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0150","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/imm.12903","article-title":"The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders","volume":"154","author":"Dopkins","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0155","article-title":"Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: a systematic review","volume":"13","author":"Fathi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0160","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.neuropharm.2016.06.020","article-title":"Cinnabarinic acid and xanthurenic acid: two kynurenine metabolites that interact with metabotropic glutamate receptors","volume":"112","author":"Fazio","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0165","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ana.24497","article-title":"Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque","volume":"78","author":"Frischer","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122846","article-title":"Improved LC-MS\/MS method for the determination of 42 neurologically and metabolically important molecules in urine","volume":"1179","author":"Galla","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.461775","article-title":"Simultaneous determination of 30 neurologically and metabolically important molecules: a sensitive and selective way to measure tyrosine and tryptophan pathway metabolites and other biomarkers in human serum and cerebrospinal fluid","volume":"1635","author":"Galla","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2018.00013","article-title":"Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism","volume":"8","author":"Gao","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0185","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(08)70191-1","article-title":"Grey matter pathology in multiple sclerosis","volume":"7","author":"Geurts","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104165","article-title":"Gut microbiome in multiple sclerosis-related cognitive impairment","volume":"67","author":"Ghadiri","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0304-3940(91)90889-2","article-title":"Excitotoxic index \u2014 a biochemical marker of selective vulnerability","volume":"127","author":"Globus","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0200","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/978-1-4615-4709-9_50","article-title":"Radical scavenging properties of tryptophan metabolites. Estimation of their radical reactivity","volume":"467","author":"Goda","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuropharm.2016.03.013","article-title":"Kynurenine pathway metabolites and enzymes involved in redox reactions","volume":"112","author":"Gonz\u00e1lez Esquivel","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4137\/IJTR.S2469","article-title":"The physiological action of picolinic acid in the human brain","volume":"2","author":"Grant","year":"2009","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00073","article-title":"Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned","volume":"8","author":"Gudi","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0220","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1046\/j.1460-9568.1999.00806.x","article-title":"3-hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum","volume":"11","author":"Guidetti","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0225","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0230","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0404.2005.00442.x","article-title":"Kynurenine metabolism in multiple sclerosis","volume":"112","author":"Hartai","year":"2005","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110403","article-title":"Cuprizone-induced demyelination provokes abnormal intrinsic properties and excitatory synaptic transmission in the male mouse anterior cingulate cortex","volume":"271","author":"Kawabata","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0245","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000086295","article-title":"Age-related increase of kynurenic acid in human cerebrospinal fluid - IgG and beta2-microglobulin changes","volume":"14","author":"Kepplinger","year":"2005","journal-title":"Neurosignals"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0250","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1471-4159.1989.tb01881.x","article-title":"A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists","volume":"52","author":"Kessler","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bpa.12454","article-title":"Multiple sclerosis animal models: a clinical and histopathological perspective","volume":"27","author":"Kipp","year":"2017","journal-title":"Brain Pathol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0260","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12663","article-title":"Cognitive disturbances in the cuprizone model of multiple sclerosis","volume":"20","author":"Kopanitsa","year":"2021","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","article-title":"The Y-maze for assessment of spatial working and reference memory in mice","volume":"1916","author":"Kraeuter","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0270","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ajpath.2011.05.048","article-title":"The tryptophan metabolite 3-Hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation","volume":"179","author":"Krause","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0275","article-title":"Kynurenine pathway dysregulation as a mechanistic link between cognitive impairment and brain damage: implications for multiple sclerosis","author":"Kupjetz","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104952","article-title":"Managing cognitive impairment and its impact in multiple sclerosis: an Australian multidisciplinary perspective","volume":"79","author":"Lechner-Scott","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0285","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.intimp.2013.08.018","article-title":"The tryptophan metabolite 3-hydroxyanthranilic acid suppresses T cell responses by inhibiting dendritic cell activation","volume":"17","author":"Lee","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0290","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuint.2006.04.017","article-title":"In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain","volume":"50","author":"Leipnitz","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0295","article-title":"Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression","volume":"7","author":"Lim","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038349","article-title":"The antioxidant role of xanthurenic acid in the Aedes aegypti midgut during digestion of a blood meal","volume":"7","author":"Lima","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0305","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00246","article-title":"Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis","volume":"7","author":"Lovelace","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0315","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","article-title":"Remyelination in multiple sclerosis: from basic science to clinical translation","volume":"19","author":"Lubetzki","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0320","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ntt.2011.07.002","article-title":"On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress","volume":"33","author":"Lugo-Huitr\u00f3n","year":"2011","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0325","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/104024","article-title":"Quinolinic acid: an endogenous neurotoxin with multiple targets","volume":"2013","author":"Lugo-Huitr\u00f3n","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0330","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10072-010-0369-3","article-title":"Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration","volume":"31","author":"Mandolesi","year":"2010","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0335","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41398-023-02555-7","article-title":"Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis","volume":"13","author":"Margoni","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0340","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3390\/biomedicines10040849","article-title":"Memory enhancement with kynurenic acid and its mechanisms in neurotransmission","volume":"10","author":"Martos","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0345","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0350","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/qjmed\/hcx070","article-title":"Cognitive dysfunction in early multiple sclerosis: a review","volume":"111","author":"McNicholas","year":"2018","journal-title":"QJM: Int. J. Med."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0355","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1007\/s10072-021-05165-7","article-title":"Cognitive impairment in multiple sclerosis: diagnosis and monitoring","volume":"42","author":"Meca-Lallana","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0360","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.4049\/jimmunol.150.9.4031","article-title":"Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages","volume":"150","author":"Melillo","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0365","doi-asserted-by":"crossref","first-page":"8128","DOI":"10.1016\/S0021-9258(17)37169-7","article-title":"Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid","volume":"269","author":"Melillo","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0370","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/acschemneuro.0c00695","article-title":"Gut microbiota changes in experimental autoimmune encephalomyelitis and cuprizone mice models","volume":"12","author":"Moles","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0375","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.nic.2024.03.010","article-title":"Cognitive impairment in multiple sclerosis: past, present, and future","volume":"34","author":"Morrow","year":"2024","journal-title":"Neuroimaging Clin. N. Am."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0380","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3177\/jnsv.47.306","article-title":"Xanthurenic acid inhibits metal ion-induced lipid peroxidation and protects NADP-isocitrate dehydrogenase from oxidative inactivation","volume":"47","author":"Murakami","year":"2001","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00238","article-title":"Interplay between age and neuroinflammation in multiple sclerosis: effects on motor and cognitive functions","volume":"10","author":"Musella","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0390","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0395","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/npp.2013.4","article-title":"Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other vglut inhibitors","volume":"38","author":"Neale","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0400","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.4049\/jimmunol.1601139","article-title":"Amino acid catabolism in multiple sclerosis affects immune homeostasis","volume":"198","author":"Negrotto","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0405","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuint.2019.03.018","article-title":"Pathological changes in mice with long term cuprizone administration","volume":"126","author":"Nomura","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0410","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1073\/pnas.93.22.12553","article-title":"Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine","volume":"93","author":"Okuda","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0415","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","article-title":"3-hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity","volume":"70","author":"Okuda","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0420","article-title":"Anthranilic acid: a potential biomarker and treatment target for schizophrenia","volume":"4","author":"Oxenkrug","year":"2016","journal-title":"Ann. Psychiatry Ment. Health"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0425","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00894-015-2758-2","article-title":"Free-radical scavenging by tryptophan and its metabolites through electron transfer based processes","volume":"21","author":"P\u00e9rez-Gonz\u00e1lez","year":"2015","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0430","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.expneurol.2010.03.009","article-title":"Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats","volume":"224","author":"Pierozan","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06124","article-title":"Cuprizone markedly decreases kynurenic acid levels in the rodent brain tissue and plasma","volume":"7","author":"Poly\u00e1k","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030945","article-title":"The tryptophan-kynurenine metabolic system is suppressed in cuprizone-induced model of demyelination simulating progressive multiple sclerosis","volume":"11","author":"Poly\u00e1k","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0445","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/ijms26030976","article-title":"Plasma and visceral organ kynurenine metabolites correlate in the multiple sclerosis cuprizone animal model","volume":"26","author":"Poly\u00e1k","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0450","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","article-title":"Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis","volume":"47","author":"Praet","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0455","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2006.03.051","article-title":"Kynurenic acid has a dual action on AMPA receptor responses","volume":"402","author":"Prescott","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006344","article-title":"The excitotoxin quinolinic acid induces tau phosphorylation in human neurons","volume":"4","author":"Rahman","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0465","doi-asserted-by":"crossref","first-page":"18270","DOI":"10.3390\/ijms160818270","article-title":"Kynurenines and multiple sclerosis: the dialogue between the immune system and the central nervous system","volume":"16","author":"Rajda","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082665","article-title":"Cerebrospinal fluid neurofilament light chain is associated with kynurenine pathway metabolite changes in multiple sclerosis","volume":"21","author":"Rajda","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0475","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2371895","article-title":"3-hydroxykynurenine and 3-Hydroxyanthranilic acid enhance the toxicity induced by copper in rat astrocyte culture","volume":"2017","author":"Ram\u00edrez-Ortega","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0480","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0485","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0304-3940(02)00710-3","article-title":"Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients","volume":"331","author":"Rejdak","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0490","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00702-007-0667-y","article-title":"Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis","volume":"114","author":"Rejdak","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0495","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuro.2015.08.003","article-title":"Mitochondrial dysfunction related to cell damage induced by 3-hydroxykynurenine and 3-hydroxyanthranilic acid: non-dependent-effect of early reactive oxygen species production","volume":"50","author":"Reyes-Ocampo","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0500","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00966592","article-title":"Quinolinic acid is a potent lipid peroxidant in rat brain homogenates","volume":"16","author":"Rios","year":"1991","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0505","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00702-008-0052-5","article-title":"The Janus-face kynurenic acid","volume":"115","author":"R\u00f3zsa","year":"2008","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0510","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.0b013e31828cf82f","article-title":"Cognitive impairment differs between primary progressive and relapsing-remitting MS","volume":"80","author":"Ruet","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0515","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.3390\/molecules26113423","article-title":"Neurodegeneration in multiple sclerosis: symptoms of silent progression, biomarkers and neuroprotective therapy\u2014kynurenines are important players","volume":"26","author":"Sandi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103667","article-title":"Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients","author":"Saraste","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0525","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.conb.2020.01.005","article-title":"Gut-brain communication in demyelinating disorders","volume":"62","author":"Sauma","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0530","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neubiorev.2019.08.008","article-title":"Behavioural phenotypes in the cuprizone model of central nervous system demyelination","volume":"107","author":"Sen","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0535","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200372","article-title":"Dysregulation of the kynurenine pathway in relapsing remitting multiple sclerosis and its correlations with progressive neurodegeneration","volume":"12","author":"Staats Pires","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0540","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/bph.12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0545","article-title":"Exploring the roles of tryptophan metabolism in MS beyond neuroinflammation and neurodegeneration: a paradigm shift to neuropsychiatric symptoms","volume":"12","author":"Tan","year":"2021","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.pnpbp.2026.111795_bb0550","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-022-02513-5","article-title":"Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents\u2014in celebration of 80th birthday of professor Peter Riederer","author":"Tanaka","year":"2022","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113246","article-title":"A validated UHPLC-MS method for tryptophan metabolites: application in the diagnosis of multiple sclerosis","volume":"185","author":"T\u00f6m\u00f6si","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0560","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"V\u00e9csei","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0565","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.pnpbp.2026.111795_bb0570","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41583-024-00823-z","article-title":"The neuropathobiology of multiple sclerosis","volume":"25","author":"Woo","year":"2024","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626001934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626001934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:22:09Z","timestamp":1785133329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626001934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":114,"alternative-id":["S0278584626001934"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111795","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term cuprizone administration resulted in cognitive decline and kynurenine metabolic disturbance: novel findings","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111795","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111795"}}